In vitro Susceptibility Analysis of Escherichia coli Strains Isolated from Urinary Tract Infections to Fosfomycin, Nitrofurantoin and Ciprofloxacin

In vitro Susceptibility Analysis of Escherichia coli Strains Isolated from Urinary Tract Infections to Fosfomycin, Nitrofurantoin and Ciprofloxacin

Introduction: Escherichia coli is the most commonly isolated microorganism from uncomplicated lower urinary tract infections (UTI). The occurrence of high ciprofloxacin resistance and production of extended spectrum beta-lactamase (ESBL) in E. coli isolates have led the researchers to investigate ne...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mediterranean journal of infection, microbes & antimicrobials microbes & antimicrobials, 2015-01, Vol.4
Hauptverfasser: SOYDAN, Sevda, KARADAG, Gülkan, ÇALISKAN, Emel, KALE, Ebru
Format: Artikel
Sprache:eng ; tur
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Mediterranean journal of infection, microbes & antimicrobials
container_volume 4
creator SOYDAN, Sevda
KARADAG, Gülkan
ÇALISKAN, Emel
KALE, Ebru
description Introduction: Escherichia coli is the most commonly isolated microorganism from uncomplicated lower urinary tract infections (UTI). The occurrence of high ciprofloxacin resistance and production of extended spectrum beta-lactamase (ESBL) in E. coli isolates have led the researchers to investigate new treatment approaches. Materials and Methods: A total of 366 E. coli strains isolated from urine samples of patients with the diagnosis of UTI, who were referred to our laboratory from different departments at our hospital, were included in this study. Results: Ninety (24.6%) isolates were found to be ESBL-positive and 276 (75.4%) were ESBL-negative. The rates of susceptibility to fosfomycin, nitrofurantoin and ciprofloxacin in ESBL-positive and ESBL-negative E. coli strains were found to be 100% and 99.7%, 80% and 90.6%, and 40% and 80.8%, respectively. Conclusion: In conclusion, ciprofloxacin resistance was high and resistance to fosfomycin and nitrofurantoin was very low in E. coli. Therefore, we assume that fosfomycin and nitrofurantoin can be used as empiric therapy for uncomplicated UTI caused by E. coli.
doi_str_mv 10.4274/mjima.2015.3
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1847440248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4273580871</sourcerecordid><originalsourceid>FETCH-proquest_journals_18474402483</originalsourceid><addsrcrecordid>eNqNzsFKAzEUBdAgCC3aXT_ggVs7JjOpM1spLc7GTSu4KzFN6BsyeTUvI853-MOO4Ae4unA5cK8QSyULXdb6oe-wN0Up1bqorsS8VLpePdbV20wsmDsppWrWlZJqLr7bCJ-YE8F-YOsuGd8xYB7hKZowMjKQhy3bs0toz2jAUkDY52QwMrRMwWR3Ap-oh9eE0aQRDsnYDG30zmakiWWCHbGnfrQY7-Hld88PycRMGMHEE2zwMlWBvswkbsW1N4Hd4i9vxN1ue9g8rybzMTjOx46GNP3jo2p0rbUsdVP9T_0AHnFd7w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1847440248</pqid></control><display><type>article</type><title>In vitro Susceptibility Analysis of Escherichia coli Strains Isolated from Urinary Tract Infections to Fosfomycin, Nitrofurantoin and Ciprofloxacin</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>SOYDAN, Sevda ; KARADAG, Gülkan ; ÇALISKAN, Emel ; KALE, Ebru</creator><creatorcontrib>SOYDAN, Sevda ; KARADAG, Gülkan ; ÇALISKAN, Emel ; KALE, Ebru</creatorcontrib><description>Introduction: Escherichia coli is the most commonly isolated microorganism from uncomplicated lower urinary tract infections (UTI). The occurrence of high ciprofloxacin resistance and production of extended spectrum beta-lactamase (ESBL) in E. coli isolates have led the researchers to investigate new treatment approaches. Materials and Methods: A total of 366 E. coli strains isolated from urine samples of patients with the diagnosis of UTI, who were referred to our laboratory from different departments at our hospital, were included in this study. Results: Ninety (24.6%) isolates were found to be ESBL-positive and 276 (75.4%) were ESBL-negative. The rates of susceptibility to fosfomycin, nitrofurantoin and ciprofloxacin in ESBL-positive and ESBL-negative E. coli strains were found to be 100% and 99.7%, 80% and 90.6%, and 40% and 80.8%, respectively. Conclusion: In conclusion, ciprofloxacin resistance was high and resistance to fosfomycin and nitrofurantoin was very low in E. coli. Therefore, we assume that fosfomycin and nitrofurantoin can be used as empiric therapy for uncomplicated UTI caused by E. coli.</description><identifier>EISSN: 2147-673X</identifier><identifier>DOI: 10.4274/mjima.2015.3</identifier><language>eng ; tur</language><publisher>Ankara: Galenos Publishing House</publisher><ispartof>Mediterranean journal of infection, microbes &amp; antimicrobials, 2015-01, Vol.4</ispartof><rights>Copyright Galenos Yayinevi 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27922,27923</link.rule.ids></links><search><creatorcontrib>SOYDAN, Sevda</creatorcontrib><creatorcontrib>KARADAG, Gülkan</creatorcontrib><creatorcontrib>ÇALISKAN, Emel</creatorcontrib><creatorcontrib>KALE, Ebru</creatorcontrib><title>In vitro Susceptibility Analysis of Escherichia coli Strains Isolated from Urinary Tract Infections to Fosfomycin, Nitrofurantoin and Ciprofloxacin</title><title>Mediterranean journal of infection, microbes &amp; antimicrobials</title><description>Introduction: Escherichia coli is the most commonly isolated microorganism from uncomplicated lower urinary tract infections (UTI). The occurrence of high ciprofloxacin resistance and production of extended spectrum beta-lactamase (ESBL) in E. coli isolates have led the researchers to investigate new treatment approaches. Materials and Methods: A total of 366 E. coli strains isolated from urine samples of patients with the diagnosis of UTI, who were referred to our laboratory from different departments at our hospital, were included in this study. Results: Ninety (24.6%) isolates were found to be ESBL-positive and 276 (75.4%) were ESBL-negative. The rates of susceptibility to fosfomycin, nitrofurantoin and ciprofloxacin in ESBL-positive and ESBL-negative E. coli strains were found to be 100% and 99.7%, 80% and 90.6%, and 40% and 80.8%, respectively. Conclusion: In conclusion, ciprofloxacin resistance was high and resistance to fosfomycin and nitrofurantoin was very low in E. coli. Therefore, we assume that fosfomycin and nitrofurantoin can be used as empiric therapy for uncomplicated UTI caused by E. coli.</description><issn>2147-673X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNzsFKAzEUBdAgCC3aXT_ggVs7JjOpM1spLc7GTSu4KzFN6BsyeTUvI853-MOO4Ae4unA5cK8QSyULXdb6oe-wN0Up1bqorsS8VLpePdbV20wsmDsppWrWlZJqLr7bCJ-YE8F-YOsuGd8xYB7hKZowMjKQhy3bs0toz2jAUkDY52QwMrRMwWR3Ap-oh9eE0aQRDsnYDG30zmakiWWCHbGnfrQY7-Hld88PycRMGMHEE2zwMlWBvswkbsW1N4Hd4i9vxN1ue9g8rybzMTjOx46GNP3jo2p0rbUsdVP9T_0AHnFd7w</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>SOYDAN, Sevda</creator><creator>KARADAG, Gülkan</creator><creator>ÇALISKAN, Emel</creator><creator>KALE, Ebru</creator><general>Galenos Publishing House</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EDSIH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20150101</creationdate><title>In vitro Susceptibility Analysis of Escherichia coli Strains Isolated from Urinary Tract Infections to Fosfomycin, Nitrofurantoin and Ciprofloxacin</title><author>SOYDAN, Sevda ; KARADAG, Gülkan ; ÇALISKAN, Emel ; KALE, Ebru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_18474402483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; tur</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SOYDAN, Sevda</creatorcontrib><creatorcontrib>KARADAG, Gülkan</creatorcontrib><creatorcontrib>ÇALISKAN, Emel</creatorcontrib><creatorcontrib>KALE, Ebru</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Turkey Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Mediterranean journal of infection, microbes &amp; antimicrobials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SOYDAN, Sevda</au><au>KARADAG, Gülkan</au><au>ÇALISKAN, Emel</au><au>KALE, Ebru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro Susceptibility Analysis of Escherichia coli Strains Isolated from Urinary Tract Infections to Fosfomycin, Nitrofurantoin and Ciprofloxacin</atitle><jtitle>Mediterranean journal of infection, microbes &amp; antimicrobials</jtitle><date>2015-01-01</date><risdate>2015</risdate><volume>4</volume><eissn>2147-673X</eissn><abstract>Introduction: Escherichia coli is the most commonly isolated microorganism from uncomplicated lower urinary tract infections (UTI). The occurrence of high ciprofloxacin resistance and production of extended spectrum beta-lactamase (ESBL) in E. coli isolates have led the researchers to investigate new treatment approaches. Materials and Methods: A total of 366 E. coli strains isolated from urine samples of patients with the diagnosis of UTI, who were referred to our laboratory from different departments at our hospital, were included in this study. Results: Ninety (24.6%) isolates were found to be ESBL-positive and 276 (75.4%) were ESBL-negative. The rates of susceptibility to fosfomycin, nitrofurantoin and ciprofloxacin in ESBL-positive and ESBL-negative E. coli strains were found to be 100% and 99.7%, 80% and 90.6%, and 40% and 80.8%, respectively. Conclusion: In conclusion, ciprofloxacin resistance was high and resistance to fosfomycin and nitrofurantoin was very low in E. coli. Therefore, we assume that fosfomycin and nitrofurantoin can be used as empiric therapy for uncomplicated UTI caused by E. coli.</abstract><cop>Ankara</cop><pub>Galenos Publishing House</pub><doi>10.4274/mjima.2015.3</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2147-673X
ispartof Mediterranean journal of infection, microbes & antimicrobials, 2015-01, Vol.4
issn 2147-673X
language eng ; tur
recordid cdi_proquest_journals_1847440248
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title In vitro Susceptibility Analysis of Escherichia coli Strains Isolated from Urinary Tract Infections to Fosfomycin, Nitrofurantoin and Ciprofloxacin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T18%3A59%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20Susceptibility%20Analysis%20of%20Escherichia%20coli%20Strains%20Isolated%20from%20Urinary%20Tract%20Infections%20to%20Fosfomycin,%20Nitrofurantoin%20and%20Ciprofloxacin&rft.jtitle=Mediterranean%20journal%20of%20infection,%20microbes%20&%20antimicrobials&rft.au=SOYDAN,%20Sevda&rft.date=2015-01-01&rft.volume=4&rft.eissn=2147-673X&rft_id=info:doi/10.4274/mjima.2015.3&rft_dat=%3Cproquest%3E4273580871%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1847440248&rft_id=info:pmid/&rfr_iscdi=true